SI1578406T1 - Farmacevtska oblika s prirejenim sproščanjem - Google Patents

Farmacevtska oblika s prirejenim sproščanjem

Info

Publication number
SI1578406T1
SI1578406T1 SI200331331T SI200331331T SI1578406T1 SI 1578406 T1 SI1578406 T1 SI 1578406T1 SI 200331331 T SI200331331 T SI 200331331T SI 200331331 T SI200331331 T SI 200331331T SI 1578406 T1 SI1578406 T1 SI 1578406T1
Authority
SI
Slovenia
Prior art keywords
pharmaceutical composition
modified release
release pharmaceutical
coated
granulate
Prior art date
Application number
SI200331331T
Other languages
English (en)
Inventor
Janez Kerc
Original Assignee
Lek Pharmaceuticals D.D.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SI200200318A external-priority patent/SI21349A/sl
Priority claimed from SI200300246A external-priority patent/SI21602A/sl
Application filed by Lek Pharmaceuticals D.D. filed Critical Lek Pharmaceuticals D.D.
Publication of SI1578406T1 publication Critical patent/SI1578406T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI200331331T 2002-12-24 2003-12-23 Farmacevtska oblika s prirejenim sproščanjem SI1578406T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SI200200318A SI21349A (sl) 2002-12-24 2002-12-24 Plavajoča farmacevtska oblika s prirejenim sproščanjem zdravilne učinkovine
SI200300246A SI21602A (sl) 2003-09-24 2003-09-24 Plavajoča farmacevtska oblika s prirejenim sproščanjem zdravilne učinkovine
EP03777508A EP1578406B1 (en) 2002-12-24 2003-12-23 Modified release pharmaceutical composition
PCT/SI2003/000048 WO2004058230A1 (en) 2002-12-24 2003-12-23 Modified release pharmaceutical composition

Publications (1)

Publication Number Publication Date
SI1578406T1 true SI1578406T1 (sl) 2009-02-28

Family

ID=32684373

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200331331T SI1578406T1 (sl) 2002-12-24 2003-12-23 Farmacevtska oblika s prirejenim sproščanjem

Country Status (15)

Country Link
US (1) US7485322B2 (sl)
EP (1) EP1578406B1 (sl)
AT (1) ATE396712T1 (sl)
AU (1) AU2003286994A1 (sl)
BR (1) BRPI0317682B1 (sl)
CA (1) CA2509976C (sl)
DE (1) DE60321386D1 (sl)
DK (1) DK1578406T3 (sl)
EA (1) EA011373B1 (sl)
ES (1) ES2305537T3 (sl)
MX (1) MXPA05006916A (sl)
PL (1) PL207776B1 (sl)
PT (1) PT1578406E (sl)
SI (1) SI1578406T1 (sl)
WO (1) WO2004058230A1 (sl)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6607751B1 (en) * 1997-10-10 2003-08-19 Intellipharamaceutics Corp. Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) * 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US9463426B2 (en) * 2005-06-24 2016-10-11 Boston Scientific Scimed, Inc. Methods and systems for coating particles
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
WO2007112581A1 (en) * 2006-04-03 2007-10-11 Isa Odidi Controlled release delivery device comprising an organosol coat
EP2010162A4 (en) * 2006-04-03 2013-01-09 Isa Odidi COMPOSITION FOR DISPOSING A MEDICINAL PRODUCT
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
PL216542B1 (pl) * 2008-03-20 2014-04-30 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Sposób wytwarzania stabilnej kompozycji orlistatu w postaci kapsułkowanego proszku
TW201117812A (en) 2009-08-05 2011-06-01 Idenix Pharmaceuticals Inc Macrocyclic serine protease inhibitors
WO2011056764A1 (en) 2009-11-05 2011-05-12 Ambit Biosciences Corp. Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles
RU2554087C2 (ru) 2009-12-18 2015-06-27 Айденикс Фармасьютикалз, Инк. 5,5-конденсированные ариленовые или гетероариленовые ингибиторы вируса гепатита с
WO2011094890A1 (en) 2010-02-02 2011-08-11 Argusina Inc. Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
WO2011112689A2 (en) 2010-03-11 2011-09-15 Ambit Biosciences Corp. Saltz of an indazolylpyrrolotriazine
ES2581840T3 (es) 2010-09-01 2016-09-07 Ambit Biosciences Corporation Pirazolilaminoquinazolina ópticamente activa y composiciones farmacéuticas y métodos de uso de la misma
AU2011296046B2 (en) 2010-09-01 2015-05-14 Ambit Biosciences Corporation Hydrobromide salts of a pyrazolylaminoquinazoline
WO2012078649A1 (en) 2010-12-06 2012-06-14 Follica, Inc. Methods for treating baldness and promoting hair growth
WO2012080050A1 (en) 2010-12-14 2012-06-21 F. Hoffmann-La Roche Ag Solid forms of a phenoxybenzenesulfonyl compound
CA2825152A1 (en) 2011-01-31 2012-08-09 Celgene Corporation Pharmaceutical compositions of cytidine analogs and methods of use thereof
AR085352A1 (es) 2011-02-10 2013-09-25 Idenix Pharmaceuticals Inc Inhibidores macrociclicos de serina proteasa, sus composiciones farmaceuticas y su uso para tratar infecciones por hcv
US20120252721A1 (en) 2011-03-31 2012-10-04 Idenix Pharmaceuticals, Inc. Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
EP2765998A1 (en) 2011-10-11 2014-08-20 Ranbaxy Laboratories Limited A gastroretentive dosage system and process of preparation thereof
EP2852586A1 (en) 2012-03-16 2015-04-01 Axikin Pharmaceuticals, Inc. 3,5-diaminopyrazole kinase inhibitors
NZ631142A (en) 2013-09-18 2016-03-31 Axikin Pharmaceuticals Inc Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
EP3046924A1 (en) 2013-09-20 2016-07-27 IDENIX Pharmaceuticals, Inc. Hepatitis c virus inhibitors
WO2015134560A1 (en) 2014-03-05 2015-09-11 Idenix Pharmaceuticals, Inc. Solid forms of a flaviviridae virus inhibitor compound and salts thereof
US10202398B2 (en) 2014-03-20 2019-02-12 Capella Therapeutics, Inc. Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer
MX2016012097A (es) 2014-03-20 2017-04-27 Capella Therapeutics Inc Derivados de bencimidazol como inhibidores de tirosina cinasa erbb para el tratamiento del cáncer.
MY191736A (en) 2014-12-23 2022-07-13 Axikin Pharmaceuticals Inc 3,5-diaminopyrazole kinase inhibitors
CN107007838B (zh) * 2016-09-30 2021-07-20 南京优科制药有限公司 一种含有马来酸依那普利、叶酸和酸稳定剂的药物组合物
CN113768898A (zh) * 2021-09-14 2021-12-10 江苏万邦生化医药集团有限责任公司 悬浮的胶囊片

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1815902A (en) * 1927-07-16 1931-07-28 Nat Aniline & Chem Co Inc Device for administering medicaments
US2340037A (en) * 1941-09-08 1944-01-25 Zipper Alfred Irving Capsule
US3186910A (en) * 1962-03-08 1965-06-01 Jacob A Glassman Method for producing peroral capsules
JPS5512411B2 (sl) * 1974-03-12 1980-04-02
US4140755A (en) * 1976-02-13 1979-02-20 Hoffmann-La Roche Inc. Sustained release tablet formulations
US4681583A (en) * 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
US4601896A (en) * 1984-03-21 1986-07-22 Mark Nugent Pharmaceutical capsule compositions and structures for gastric sensitive materials
DE3627423A1 (de) * 1986-08-13 1988-02-18 Thomae Gmbh Dr K Arzneimittel enthaltend dipyridamol oder mopidamol und o-acetylsalicylsaeure bzw. deren physiologisch vertraegliche salze, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung der thrombusbildung
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
US5002772A (en) * 1988-05-31 1991-03-26 Pfizer Inc. Gastric retention system for controlled drug release
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form
US5387421A (en) * 1991-01-31 1995-02-07 Tsrl, Inc. Multi stage drug delivery system
US5314696A (en) * 1991-06-27 1994-05-24 Paulos Manley A Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor
US5169638A (en) * 1991-10-23 1992-12-08 E. R. Squibb & Sons, Inc. Buoyant controlled release powder formulation
US5223265A (en) * 1992-01-10 1993-06-29 Alza Corporation Osmotic device with delayed activation of drug delivery
JP2959423B2 (ja) 1994-12-01 1999-10-06 シオノギクオリカプス株式会社 カプセル用皮膜組成物
AU7375598A (en) 1997-05-09 1998-11-27 Sage Pharmaceuticals, Inc. Stable oral pharmaceutical dosage forms
KR100695562B1 (ko) * 1998-09-28 2007-03-15 워너-램버트 캄파니 엘엘씨 Ｈｐｍｃ 캡슐을 이용한 장 및 결장에의 전달방법
AU773800B2 (en) * 1999-07-30 2004-06-10 Capsugel Belgium Nv Multi-component pharmaceutical dosage form
US7674480B2 (en) 2000-06-23 2010-03-09 Teva Pharmaceutical Industries Ltd. Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
US20030194430A1 (en) * 2002-04-10 2003-10-16 Miller Frederick H. Process for encapsulating multi-phase, multi-compartment capsules for therapeutic compositions

Also Published As

Publication number Publication date
PT1578406E (pt) 2008-09-01
BR0317682A (pt) 2005-11-29
PL207776B1 (pl) 2011-01-31
DE60321386D1 (de) 2008-07-10
BRPI0317682B1 (pt) 2015-04-14
MXPA05006916A (es) 2005-08-18
EA011373B1 (ru) 2009-02-27
WO2004058230A1 (en) 2004-07-15
ES2305537T3 (es) 2008-11-01
CA2509976C (en) 2012-03-13
DK1578406T3 (da) 2008-09-08
EA200500909A1 (ru) 2006-02-24
US20040131669A1 (en) 2004-07-08
EP1578406B1 (en) 2008-05-28
ATE396712T1 (de) 2008-06-15
PL376099A1 (en) 2005-12-12
CA2509976A1 (en) 2004-07-15
AU2003286994A1 (en) 2004-07-22
US7485322B2 (en) 2009-02-03
EP1578406A1 (en) 2005-09-28

Similar Documents

Publication Publication Date Title
SI1578406T1 (sl) Farmacevtska oblika s prirejenim sproščanjem
MXPA03007712A (es) Sales farmaceuticas.
IL245365A0 (en) ATP-linked cassette transport modulators, pharmaceutical preparations containing them and their uses
WO2004058837A3 (de) Ampholytisches copolymer und dessen verwendung
PT1439829E (pt) Medicamento contendo 3-(3-dimetilamino-1-etil-2-metilpropil)-fenol proporcionando libertacao retardada da substancia activa
HK1046244A1 (en) Controlled release and taste masking oral pharmaceutical compositions.
EG25011A (en) Amino-piperidin-1-yl-xanthines, the production thereof and the use of the same as medicaments.
IL163552A (en) Conjugates of biologically active compounds, uses thereof and pharmaceutical compositions comprising the same
AU2003211951A1 (en) N-carbamoyl nitrogen-containing fused ring compounds and drugs containing these compounds as the active ingredient
HUP0402293A3 (en) Orodispersible tablets containing fexofenadine, coated granules and process for its preparation
AU2003274071A1 (en) Dosage form that is safeguarded from abuse
AR033711A1 (es) Composiciones farmaceuticas
WO2005007137A3 (de) Ambroxolhaltige tabletten
HUP0400155A3 (en) N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
AU2002238855A1 (en) N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
HRP20041193A2 (en) Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release
MXPA03008420A (es) Forma farmaceutica solida oralmente dispersa.
GB0127706D0 (en) The Drug and bug cap
CA2379314A1 (en) Tablet for sucking, containing ambroxol
WO2004062552A3 (en) Pharmaceutical composition containing a nsaid and a benzimidazole derivative
IL157065A0 (en) 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
WO2004024128A3 (en) Modified release ketoprofen dosage form
MXPA01008348A (es) Microcapsulas para la liberacion prolongada de farmacos.
EA200300128A1 (ru) Фармацевтические композиции, содержащие карбонат лития
HUP0202594A3 (en) Streptogramin derivatives, production thereof and pharmaceutical compositions containing the same